||||||||||TT11 / Tessa Therap, UNC Lineberger Comprehensive Cancer Center, Baylor Scott & White Research Institute New P1 trial: Administration of T Lymphocytes for Prevention of Relapse of Lymphomas (clinicaltrials.gov) - Jan 26, 2016 P1, N=18, Not yet recruiting, Sponsor: UNC Lineberger Comprehensive Cancer Center